
Zydus Lifesciences to Raise up to Rs. 5,000 Crores through Fundraising
Zydus Lifesciences Ltd. has informed the BSE that the company's Board of Directors will meet on 06/11/2025 to consider and approve a proposal for fundraising. The company plans to raise up to Rs. 5,000 Crores through various methods such as qualified institutions placement(s), rights issue, preferential allotment or a private placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws. The fundraising is subject to the approval of the members of the Company and such regulatory / statutory approvals as may be required. The company may also convene a postal ballot process to seek approval of the shareholders of the Company in respect of the aforesaid proposal. The trading window for dealing in the securities of the Company will be closed for the designated persons and their immediate relatives till the expiry of 48 hours after the conclusion of the meeting of the Board.
Key Highlights
- Zydus Lifesciences to raise up to Rs. 5,000 Crores through fundraising
- Fundraising to be done through various methods such as qualified institutions placement(s), rights issue, preferential allotment or a private placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws
- Subject to approval of the members of the Company and such regulatory / statutory approvals as may be required
- Company may convene a postal ballot process to seek approval of the shareholders
- Trading window for dealing in the securities of the Company to be closed for the designated persons and their immediate relatives till the expiry of 48 hours after the conclusion of the meeting of the Board